Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.06.12
Views: 33336

Dr Maha Hussain - University of Michigan, Ann Arbor, USA

Dr Maha Hussain talks to ecancer about differences in outcome after using intermittent and continuous hormone therapy for advanced prostate cancer at the ASCO 2012 Annual Meeting in Chicago, June 2012.


Dr Hussain's study found that intermittent hormonal therapy is less effective than continuous hormonal therapy in men with minimal disease spread. Although, in men with more extensive disease spread, the results indicate that intermittent and continuous therapy are comparably effective.


Audio only

Related videos

follow us

Biosimilar Medicines Core Principles and Communication

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation